ASCPT Podcast Channel

ClinPharmPod’s peer review series continues as host Alaina Webster is chats with Dr. Richard Peck about what to avoid when completing a review. They cover what’s too little and what’s too much in a review, the appropriate tone to strike when providing feedback, and the tricky topic that is unconscious bias.

You can access CPT’s Reviewer Instructions and contact the editorial office to volunteer as a reviewer here.

Dr. Erica Woodahl is back as moderator to discuss “Applying an equity lens to pharmacogenetic research and translation to underrepresented populations” with Clinical and Translational Science authors Drs. Tiana Luczak and Jacob Brown. They break down the challenges to conducting pharmacogenetic studies in underrepresented populations, what steps researchers can take to overcome these obstacles, and why equitable studies for underrepresented groups is vital to the future of clinical pharmacology and translational science.

You can access Tiana and Jacob’s fully Open Access paper here.

In the second installment of ClinPharmPod’s six-part peer review series, host Alaina Webster is joined by returning guest Dr. Deanna Kroetz, Professor at the University of California, San Francisco in the Department of Bioengineering Therapeutic Sciences and Deputy Editor-in-Chief of Clinical and Translational Science (CTS). They break down the top three things Deanna looks for when undertaking a peer review as well as the importance of peer review to sound science.

You can access CTS’s Reviewer Instructions here.

Kicking off a six-part series on peer review, ClinPharmPod host Alaina Webster chats with Dr. Sarah Holstein, Associate Professor at the University of Nebraska Medical Center and Associate Editor for Clinical Pharmacology & Therapeutics (CPT) about the importance of peer review in scientific research and what might constitute a conflict of interest for potential reviewers.

You can access CPT’s Reviewer Instructions here.

For this episode of ClinPharmPod, host Alaina Webster sits down with Dr. Don Willis, Assistant Professor at the University of Arkansas for Medical Sciences, and moderator Dr. Erica Woodahl, Professor at the University of Montana and Associate Editor for Clinical and Translational Science (CTS). They discuss Don and his colleagues’ recent publication in CTS, “COVID-19 vaccine hesitancy: Race/ethnicity, trust, and fear,” digging into how location, race, past racism, and current systemic racism factor into the willingness to receive a COVID-19 vaccination.

On the latest episode of PSPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

On the latest episode of ClinPharmPod, host Alaina Webster is joined by France Mentré, MD, PhD, Editor-in-Chief of CPT: Pharmacometrics & Systems Pharmacology, Deanna L. Kroetz, PhD, Deputy Editor-in-Chief of Clinical and Translational Science, and Shirley K. Seo, PhD, Associate Editor of Clinical Pharmacology & Therapeutics, to discuss their experiences of how COVID-19 has affected submissions and peer review for the ASCPT Family of Journals. Brian Coughlin, Publisher at Wiley, serves as moderator for the discussion.

On this episode of PSPod, Dr. Rajanikanth Madabushi from the US Food and Drug Administration continues our recent discussion on model-informed drug development (MIDD) and its role in the successful implementation of PDUFA VI. This discussion is based on his co-authored Perspective article (with Drs. Yaning Wang and Issam Zineh) “A Holistic and Integrative Approach for Advancing Model‐Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

On this episode of PSPod, Drs. Lokesh Jain, Larissa Wenning, and Nitin Mehrotra from Merck discuss the important role model-informed drug development (MIDD) will play in the successful implementation of PDUFA VI. This discussion is based on their Perspective article “PDUFA VI: It's Time to Unleash the Full Potential of Model-Informed Drug Development” which published in the January 2019 issue of PSP. The article is available here.

On this episode of PSPod, Drs. Piet van der Graaf and Suruchi Bakshi from Certara QSP and Leiden University, and Dr. Chao Chen from Clinical Pharmacology Modelling & Simulation at  GlaxoSmithKline, discuss quantitative systems pharmacology (QSP) modeling in relation to the study of Parkinson’s disease. This discussion is based on a Review article that published in the February 2019 issue of PSP, which is available here.